These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17133201)

  • 1. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials.
    Simoni JM; Pearson CR; Pantalone DW; Marks G; Crepaz N
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(0 1):S23-35. PubMed ID: 17133201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.
    de Bruin M; Viechtbauer W; Schaalma HP; Kok G; Abraham C; Hospers HJ
    Arch Intern Med; 2010 Feb; 170(3):240-50. PubMed ID: 20142568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
    Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
    Tuldrà A; Fumaz CR; Ferrer MJ; Bayés R; Arnó A; Balagué M; Bonjoch A; Jou A; Negredo E; Paredes R; Ruiz L; Romeu J; Sirera G; Tural C; Burger D; Clotet B
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):221-8. PubMed ID: 11115952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
    Hart JE; Jeon CY; Ivers LC; Behforouz HL; Caldas A; Drobac PC; Shin SS
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):167-79. PubMed ID: 20375848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Rueda S; Park-Wyllie LY; Bayoumi AM; Tynan AM; Antoniou TA; Rourke SB; Glazier RH
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD001442. PubMed ID: 16855968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.
    Crepaz N; Hart TA; Marks G
    JAMA; 2004 Jul; 292(2):224-36. PubMed ID: 15249572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
    Katz IT; Leister E; Kacanek D; Hughes MD; Bardeguez A; Livingston E; Stek A; Shapiro DE; Tuomala R
    Ann Intern Med; 2015 Jan; 162(2):90-9. PubMed ID: 25599347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
    AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review.
    Mathes T; Pieper D; Antoine SL; Eikermann M
    HIV Med; 2013 Nov; 14(10):583-95. PubMed ID: 23773654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing Medication Nonadherence of Youth (13-24 Years) With HIV Initiating Antiretroviral Therapy.
    Ingerski LM; Means B; Wang F; Zhang H; Patel N; Gaur AH; Wilkins ML
    J Adolesc Health; 2021 Oct; 69(4):644-652. PubMed ID: 34059425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.
    Van Dyke RB; Lee S; Johnson GM; Wiznia A; Mohan K; Stanley K; Morse EV; Krogstad PA; Nachman S;
    Pediatrics; 2002 Apr; 109(4):e61. PubMed ID: 11927734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women.
    Simoni JM; Pantalone DW; Plummer MD; Huang B
    Health Psychol; 2007 Jul; 26(4):488-95. PubMed ID: 17605569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.
    Nachega JB; Hislop M; Dowdy DW; Lo M; Omer SB; Regensberg L; Chaisson RE; Maartens G
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):78-84. PubMed ID: 16878045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.
    Llabre MM; Weaver KE; Durán RE; Antoni MH; McPherson-Baker S; Schneiderman N
    AIDS Patient Care STDS; 2006 Oct; 20(10):701-11. PubMed ID: 17052140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.